Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration

PEGylated lipids are one of the four constituents of lipid nanoparticle mRNA COVID-19 vaccines. Therefore, various concerns have been raised on the generation of anti-PEG antibodies and their potential role in inducing hypersensitivity reactions following vaccination or in reducing vaccine efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrini, Giuditta, Gioria, Sabrina, Sauer, Aisha V., Lucchesi, Simone, Montagnani, Francesca, Pastore, Gabiria, Ciabattini, Annalisa, Medaglini, Donata, Calzolai, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408675/
https://www.ncbi.nlm.nih.gov/pubmed/36012103
http://dx.doi.org/10.3390/ijms23168838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408675/
https://www.ncbi.nlm.nih.gov/pubmed/36012103
http://dx.doi.org/10.3390/ijms23168838

Ejemplares similares